Copyright
©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 106228
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106228
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106228
Table 1 Clinicopathological features of gastric cancer patients according to the status of swollen lymph node metastasis, data is reported for the whole study series and for the matched pairs, n (%)
Characteristics | Whole study series | Matched pairs (case-control method) | ||||
SLNM positive (n = 368) | SLNM negative (n = 139) | P value | SLNM positive (n = 133) | SLNM negative (n = 133) | P value | |
Sex | 0.900 | 0.683 | ||||
Male | 99 (71.2) | 260 (70.7) | 97 (72.9) | 94 (70.7) | ||
Female | 40 (28.8) | 108 (29.3) | 36 (27.1) | 39 (29.3) | ||
Age (years) | 0.132 | 0.496 | ||||
< 70 | 104 (74.8) | 250 (67.9) | 98 (73.7) | 93 (69.9) | ||
≥ 70 | 35 (25.2) | 118 (32.1) | 35 (26.3) | 40 (30.1) | ||
Preoperative tumor marker | < 0.001 | 0.695 | ||||
Normal | 90 (64.7) | 297 (80.7) | 88 (66.2) | 91 (68.4) | ||
Elevated | 49 (35.3) | 71 (19.3) | 45 (33.8) | 42 (31.6) | ||
Tumor location | < 0.001 | 0.130 | ||||
Lower one-third | 46 (33.1) | 126 (34.2) | 44 (33.1) | 38 (28.6) | ||
Middle one-third | 21 (15.1) | 53 (14.4) | 19 (14.3) | 23 (17.3) | ||
Upper one-third | 27 (19.4) | 140 (38.0) | 27 (20.3) | 41 (30.8) | ||
2/3 or more | 45 (32.4) | 49 (13.3) | 43 (32.3) | 31 (23.3) | ||
Tumor size | 0.007 | 0.891 | ||||
< 5 cm | 38 (27.3) | 148 (40.2) | 36 (27.1) | 37 (27.8) | ||
≥ 5 cm | 101 (72.7) | 220 (59.8) | 97 (72.9) | 96 (72.2) | ||
Borrmann type | < 0.001 | 0.061 | ||||
I, II | 33 (23.7) | 155 (42.1) | 33 (24.8) | 47 (35.3) | ||
III, IV | 106 (76.3) | 213 (57.9) | 100 (75.2) | 86 (64.7) | ||
Histology | 0.013 | 0.769 | ||||
Differentiated | 29 (20.9) | 118 (32.1) | 29 (21.8) | 31 (23.3) | ||
Undifferentiated | 110 (79.1) | 250 (67.9) | 104 (78.2) | 102 (76.7) | ||
T stage | < 0.001 | 0.290 | ||||
T1 | 2 (1.4) | 16 (4.3) | 2 (1.5) | 0 (0.0) | ||
T2 | 2 (1.4) | 29 (7.9) | 2 (1.5) | 4 (3.0) | ||
T3 | 7 (5.0) | 53 (14.4) | 7 (5.3) | 12 (9.0) | ||
T4a | 115 (82.7) | 252 (68.5) | 111 (83.5) | 102 (76.7) | ||
T4b | 13 (9.4) | 18 (4.9) | 11 (8.3) | 15 (11.3) | ||
N stage | < 0.001 | 0.977 | ||||
N1 | 13 (9.4) | 136 (37.0) | 13 (9.8) | 12 (9.0) | ||
N2 | 49 (35.3) | 125 (34.0) | 49 (36.8) | 49 (36.8) | ||
N3 | 77 (55.4) | 107 (29.1) | 71 (53.4) | 72 (54.1) | ||
Tumor deposits | 0.039 | 0.689 | ||||
Negative | 94 (67.6) | 282 (76.6) | 91 (68.4) | 94 (70.7) | ||
Positive | 45 (32.4) | 86 (23.4) | 42 (31.6) | 39 (29.3) | ||
Lymphovascular invasion | < 0.001 | 0.122 | ||||
Negative | 83 (59.7) | 294 (79.9) | 81 (60.9) | 93 (69.9) | ||
Positive | 56 (40.3) | 74 (20.1) | 52 (39.1) | 40 (30.1) | ||
Type of gastrectomy | 0.036 | 0.454 | ||||
Subtotal | 79 (56.8) | 246 (66.8) | 76 (57.1) | 82 (61.7) | ||
Total | 60 (43.2) | 122 (33.2) | 57 (42.9) | 51 (38.3) |
- Citation: Cui JL, Zhao K, Li XL, Wang F, Yang YS, Zheng X. Swollen lymph node metastasis and survival in gastric cancer: Multi-institutional post-resection analysis. World J Clin Oncol 2025; 16(6): 106228
- URL: https://www.wjgnet.com/2218-4333/full/v16/i6/106228.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i6.106228